The activating PIK3CA mutations are present from the onset of oncogenesis in BC and are not typically lost or acquired during clonal development in the later latter phases of the disease, suggesting that they are driver mutations.10, 11, 19. The gene discussed is PIK3CA; the disease is breast cancer.